Vivosim Labs Inc Revenue per Employee (VIVS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vivosim Labs Inc   (NASDAQ: VIVS)
 

Vivosim Labs Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Vivosim Labs Inc 's Revenue per employee fell on a trailing twelve month basis to $ 2,800, below the company average number of $49,656.
Within the Healthcare sector Employees of 616 other companies have achieved higher revenue per employee. While Vivosim Labs Inc 's total ranking has deteriorated compared to the previous quarter from 3781 to 4128. Vivosim Labs Inc has 40 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VIVS Revenue per Employee (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter
Y / Y Revenue Change -51.35 % -21.57 % 8.33 % -6.67 % -5.13 %
Sales per Employee (TTM) $ 2,800 3,275 3,550 3,500 3,550
VIVS's Total Ranking # 4128 # 3781 # 3842 # 3848 # 2
Seq. Revenue Change -55 % 53.85 % -7.14 % -24.32 % -27.45 %

VIVS Company Profile >> Back to VIVS Efficiency Comparisons >> Compare VIVS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 79
Healthcare Sector # 617
Overall Market # 4128

Revenue per Employee Statistics
High Average Low
$ 115,075 $ 49,656 $ 2,800
(Mar 31 2018)   (Jun 30 2026)



Financial Statements
Vivosim Labs Inc 's Revenue MRQ $ 0 Millions Visit VIVS's Income Statement
Vivosim Labs Inc 's Revenues TTM $ 0 Millions Visit VIVS's aggregate revenue growth
What are VIVS's Sales? Visit VIVS's Sales by Segment




Other Ratios
Vivosim Labs Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
VIVS's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for VIVS's Competitors
Revenue per Employee for VIVS's Suppliers
Revenue per Employee for VIVS's Customers

You may also want to know
VIVS's Sales Growth Rates VIVS's Pe Price to earnings ratio VIVS's Receivables Turnover Ratio VIVS's Stock Quote
VIVS's Net Income Growth Rates VIVS's Ps Price to Sales ratio VIVS's Sales per Employee VIVS's Asset Turnover Ratio
VIVS's Net Margin VIVS's Pb Price to Book ratio VIVS's Financial Strength Ratios VIVS's Dividend Payout Ratio
Date modified: 2026-09-02T04:11:00+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Prokidney Corp   3,541.13 $ 0.818  Million 231 
Clene Inc   2,493.67 $ 0.197  Million 79 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.